These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30406380)

  • 21. Premalignant lesions of cholangiocarcinoma: characteristics on ultrasonography and MRI.
    Siripongsakun S; Sapthanakorn W; Mekraksakit P; Vichitpunt S; Chonyuen S; Seetasarn J; Bhumiwat S; Sricharunrat T; Srittanapong S
    Abdom Radiol (NY); 2019 Jun; 44(6):2133-2146. PubMed ID: 30820627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    Kim SJ; Lee JM; Han JK; Kim KH; Lee JY; Choi BI
    AJR Am J Roentgenol; 2007 Dec; 189(6):1428-34. PubMed ID: 18029881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients.
    Chamadol N; Pairojkul C; Khuntikeo N; Laopaiboon V; Loilome W; Sithithaworn P; Yongvanit P
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):316-22. PubMed ID: 24420706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrahepatic bile duct dilatation due to liver metastases from colorectal carcinoma.
    Jhaveri KS; Halankar J; Aguirre D; Haider M; Lockwood G; Guindi M; Fischer S
    AJR Am J Roentgenol; 2009 Sep; 193(3):752-6. PubMed ID: 19696289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential diagnosis of intrahepatic bile duct dilatation without demonstrable mass on ultrasonography or CT: benign versus malignancy.
    Kim HJ; Lee KT; Kim SH; Lee JK; Lim JH; Paik SW; Rhee JC
    J Gastroenterol Hepatol; 2003 Nov; 18(11):1287-92. PubMed ID: 14535986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings.
    Han JK; Choi BI; Kim AY; An SK; Lee JW; Kim TK; Kim SW
    Radiographics; 2002; 22(1):173-87. PubMed ID: 11796906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrahepatic peripheral cholangiocarcinoma: CT features in 18 pathologically proven cases.
    Chen H; Hui Y
    Chin Med J (Engl); 1998 May; 111(5):453-6. PubMed ID: 10374358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas.
    Komori T; Inoue D; Zen Y; Yoneda N; Kitao A; Kozaka K; Yokka A; Toshima F; Matsubara T; Kobayashi S; Gabata T
    Eur Radiol; 2019 Jun; 29(6):3132-3140. PubMed ID: 30519930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
    Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK
    Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging features of intrahepatic cholangiocarcinoma mimicking a liver abscess: an analysis of 8 cases.
    Liu M; Chen J; Huang R; Huang J; Li L; Li Y; Qin M; Qin W; Nong H; Ding K
    BMC Gastroenterol; 2021 Nov; 21(1):427. PubMed ID: 34772340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.
    Regimbeau JM; Panis Y; Nemeth J; Pocard M; de Claviere G; Soyer P; Valleur P
    Hepatogastroenterology; 2003; 50(49):21-3. PubMed ID: 12629982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients.
    Baheti AD; Tirumani SH; Shinagare AB; Rosenthal MH; Hornick JL; Ramaiya NH; Wolpin BM
    Abdom Imaging; 2014 Dec; 39(6):1193-201. PubMed ID: 24869789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
    Tsunematsu S; Chuma M; Kamiyama T; Miyamoto N; Yabusaki S; Hatanaka K; Mitsuhashi T; Kamachi H; Yokoo H; Kakisaka T; Tsuruga Y; Orimo T; Wakayama K; Ito J; Sato F; Terashita K; Nakai M; Tsukuda Y; Sho T; Suda G; Morikawa K; Natsuizaka M; Nakanishi M; Ogawa K; Taketomi A; Matsuno Y; Sakamoto N
    Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholangiocarcinoma - Part 2, Tumoral and Nontumoral Mimics and Imaging Features Helpful in Differentiation.
    Mantripragada S; Chawla A
    Curr Probl Diagn Radiol; 2022; 51(3):362-374. PubMed ID: 33627221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholangiocarcinoma at the hepatic hilus: sonographic findings.
    Hann LE; Greatrex KV; Bach AM; Fong Y; Blumgart LH
    AJR Am J Roentgenol; 1997 Apr; 168(4):985-9. PubMed ID: 9124155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of CT findings of biliary tract changes with autoimmune pancreatitis and extrahepatic bile duct cholangiocarcinoma.
    Maeda E; Akahane M; Yoshioka N; Takao H; Matsuda I; Kamiya K; Hirano K; Tada M; Ohtsu H; Fukushima N; Ohtomo K
    Jpn J Radiol; 2012 Apr; 30(3):227-34. PubMed ID: 22200917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrahepatic mass-forming cholangiocarcinoma and solitary hypovascular liver metastases: is the differential diagnosis using diffusion-weighted MRI possible?
    Kovač JD; Galun D; Đurić-Stefanović A; Lilić G; Vasin D; Lazić L; Mašulović D; Šaranović Đ
    Acta Radiol; 2017 Dec; 58(12):1417-1426. PubMed ID: 28350257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast-enhanced CT of intrahepatic and hilar cholangiocarcinoma: delay time for optimal imaging.
    Keogan MT; Seabourn JT; Paulson EK; McDermott VG; Delong DM; Nelson RC
    AJR Am J Roentgenol; 1997 Dec; 169(6):1493-9. PubMed ID: 9393152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.